32 related articles for article (PubMed ID: 28216405)
1. A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy.
Sun L; Yang N; Chen B; Bei Y; Kang Z; Zhang C; Zhang N; Xu P; Yang W; Wei J; Ke J; Sun W; Li X; Shen P
Acta Pharm Sin B; 2023 Jul; 13(7):3027-3042. PubMed ID: 37521858
[TBL] [Abstract][Full Text] [Related]
2. Novel nonsecosteroidal VDR ligands with phenyl-pyrrolyl pentane skeleton for cancer therapy.
Ge Z; Hao M; Xu M; Su Z; Kang Z; Xue L; Zhang C
Eur J Med Chem; 2016 Jan; 107():48-62. PubMed ID: 26562542
[TBL] [Abstract][Full Text] [Related]
3. Novel nonsecosteroidal VDR agonists with phenyl-pyrrolyl pentane skeleton.
Shen W; Xue J; Zhao Z; Zhang C
Eur J Med Chem; 2013 Nov; 69():768-78. PubMed ID: 24099996
[TBL] [Abstract][Full Text] [Related]
4. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
5. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
6. 1,25-Dihydroxyvitamin D
Li M; Li L; Zhang L; Hu W; Shen J; Xiao Z; Wu X; Chan FL; Cho CH
Life Sci; 2017 Jun; 179():88-97. PubMed ID: 28465245
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of nonsecosteroidal vitamin D
Wang B; Hao M; Zhang C
Bioorg Med Chem Lett; 2017 Mar; 27(6):1428-1436. PubMed ID: 28216405
[TBL] [Abstract][Full Text] [Related]
8. Structural Studies of Vitamin D Nuclear Receptor Ligand-Binding Properties.
Belorusova AY; Rochel N
Vitam Horm; 2016; 100():83-116. PubMed ID: 26827949
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 2α-(tetrazolylethyl)-1α,25-dihydroxyvitamin D3 as a high affinity ligand for vitamin D receptor.
Matsuo M; Hasegawa A; Takano M; Saito H; Kakuda S; Takagi K; Ochiai E; Horie K; Takimoto-Kamimura M; Takenouchi K; Sawada D; Kittaka A
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():201-3. PubMed ID: 24036313
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship of nonsecosteroidal vitamin D receptor modulators.
Yamada S; Makishima M
Trends Pharmacol Sci; 2014 Jul; 35(7):324-37. PubMed ID: 24865943
[TBL] [Abstract][Full Text] [Related]
11. [Current Topics on Vitamin D. Nonsecosteroidal vitamin D mudulators and prospects for their thepapeutic application].
Makishima M
Clin Calcium; 2015 Mar; 25(3):403-11. PubMed ID: 25716814
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor 2016: novel ligands and structural insights.
Maestro MA; Molnár F; Mouriño A; Carlberg C
Expert Opin Ther Pat; 2016 Nov; 26(11):1291-1306. PubMed ID: 27454349
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]